ABCC2 and hepatocellular carcinoma: MRP2 is involved in the transport of sorafenib [39], regorafenib [13], cabozantinib [12], and probably lenvatinib [23], whereas MRP3 expression has been associated with the lack of cultured HCC cell sensitivity to sorafenib [22].